IMTX: Immatics N.V. Stock

by  •  • Comments Off on IMTX: Immatics N.V. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 930.98
Enterprise Value ($M) n/a
Book Value ($M) 382.53
Book Value / Share 3.20
Price / Book n/a
NCAV ($M) 318.07
NCAV / Share 2.66
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.14
Return on Assets (ROA) -0.13
Return on Equity (ROE) -0.23

Liquidity (mrq)
Quick Ratio 3.98
Current Ratio 3.98

Balance Sheet (mrq) ($M)
Current Assets 512.78
Assets 577.23
Liabilities 194.71
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G Rtw Investments, Lp 9.70
11-14 13G T. Rowe Price Investment Management, Inc. 7.20
11-08 13G/A Wellington Management Group Llp 9.40 52.39
10-17 13D/A Perceptive Advisors Llc 7.90 15.90
06-06 13G/A Arya Sciences Holdings 0.00 -100.00
02-14 13G/A Baker Bros. Advisors Lp 6.90 12.57
02-07 13G/A Athos Kg 5.80 -0.01

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-27 98,135 385,022 25.49
2024-11-26 44,789 654,488 6.84
2024-11-25 28,244 564,401 5.00
2024-11-22 60,360 518,921 11.63

(click for more detail)

Similar Companies
IMMX – Immix Biopharma, Inc. IMNM – Immunome, Inc.
IMNN – Imunon, Inc. INDP – Indaptus Therapeutics, Inc.
INKT – MiNK Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io